Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Yanshengchao (Beijing) Biotechnology

Request full access

First-in-class drugs for inflammatory and autoimmune diseases

Dongcheng District, ChinaFounded 2022Biotech & Life Sciences

About Yanshengchao (Beijing) Biotechnology

Yanshengchao (Beijing) Biotechnology Co., Ltd. is a biopharmaceutical company founded in 2022, based on the original research of Professor Qi Hai's team at Tsinghua University's School of Medicine. The company focuses on developing first-in-class (FIC) drugs targeting novel pathways for inflammatory and autoimmune diseases. Yanshengchao was co-founded by Dr. Wang Yifeng, who serves as the CEO.

The company's primary mission is to address the significant unmet clinical needs in treating autoimmune and inflammatory conditions, aiming to overcome challenges such as insufficient efficacy, high relapse rates, and notable side effects of existing therapies. Its business model revolves around the research and development of large-molecule antibody drugs and small-molecule drugs. Yanshengchao's core pipelines include YSC001, a candidate for treating various autoimmune diseases like systemic lupus erythematosus and rheumatoid arthritis by targeting a GPCR to delete pathogenic T and B cell subsets. Another key pipeline, YSC002, is a protease-targeting therapy for chronic inflammatory diseases such as chronic sinusitis with nasal polyps, asthma, and atopic dermatitis.

Yanshengchao has secured significant funding to advance its drug development programs. In August 2025, the company completed a Series Pre-A financing round of several hundred million RMB, led by Guosheng Capital. This was followed by a Series A round of a similar amount in December 2025, led by Cathay Capital. These funds are designated for the clinical development of YSC001, preclinical development of YSC002, and early validation of other pipelines, as well as for expanding its international strategy and collaborations with multinational pharmaceutical companies. The company has also entered into a strategic cooperation with Sanofi and Cathay Capital to promote the Chinese pharmaceutical innovation ecosystem.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2
Open positions
None listed
Industry
Health
Sub-industry
BioTechnology
Sector
Drug Development, Autoimmune, Inflammatory Diseases, Immune System, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2025 $28M $110M Qiming Venture Partners · Cathay Capital ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Yanshengchao (Beijing) Biotechnology team growth

Yanshengchao (Beijing) Biotechnology's team grew 0% over the past year.

1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Yanshengchao (Beijing) Biotechnology in the Dongcheng District ecosystem

Live from Dealroom

The Yanshengchao (Beijing) Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Employees 2 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Dongcheng District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Yanshengchao (Beijing) Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Yanshengchao (Beijing) Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.